Inventor · disambiguated record

Dinah Wen-Yee Sah

Also filed as: SAH DINAH · SAH DINAH W Y · SAH DINAH WEN-YEE

53 granted patents·61 pending applications·821 citations·filing 1996–2025

98Inventor score

Technology areasC12N A61P A61K C07K C12Q

Files withVOYAGER THERAPEUTICS INC47 ALNYLAM PHARMACEUTICALS INC32 SAH DINAH WEN-YEE11 BUMCROT DAVID4 SIGNAL PHARM INC4

Top patents by PatentIndex Score

114 records

0199US7749978B2Compositions and methods for inhibiting expression of Huntingtin geneALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Jul 6, 2010·113 cites·26 claims
0299US7582745B2Compositions and methods for inhibiting expression of Nav1.8 geneALNYLAM PHARMACEUTICALS INC·Filed 2006·Granted Sep 1, 2009·152 cites·11 claims
0399US7320965B2Compositions and methods for inhibiting expression of Huntingtin geneALNYLAM PHARMACEUTICALS INC·Filed 2006·Granted Jan 22, 2008·208 cites·8 claims
0498US8168775B2Compositions and methods for inhibiting expression of transthyretinSAH DINAH WEN-YEE·Filed 2009·Granted May 1, 2012·84 cites·23 claims
0597US11193129B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2020·Granted Dec 7, 2021·8 cites·20 claims
0696US10920227B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2020·Granted Feb 16, 2021·8 cites·22 claims
0796US10584337B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2017·Granted Mar 10, 2020·15 cites·28 claims
0895US8741866B2Compositions and methods for inhibiting expression of transthyretinSAH DINAH WEN-YEE·Filed 2012·Granted Jun 3, 2014·29 cites·30 claims
0994US11603542B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2018·Granted Mar 14, 2023·7 cites·28 claims
1094US11542506B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2021·Granted Jan 3, 2023·3 cites·30 claims
1194US10597660B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2015·Granted Mar 24, 2020·11 cites·27 claims
1294US9234196B2Compositions and methods for inhibiting expression of transthyretinALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Jan 12, 2016·18 cites·37 claims
1392US11434502B2Treatment of amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2018·Granted Sep 6, 2022·5 cites·16 claims
1492US7442370B2Polymer conjugates of mutated neublastinBIOGEN IDEC INC·Filed 2003·Granted Oct 28, 2008·35 cites·68 claims
1591US10240152B2Compositions and methods for inhibiting expression of transthyretinALNYLAM PHARMACEUTICALS INC·Filed 2016·Granted Mar 26, 2019·6 cites·53 claims
1691US9212364B2Compositions and methods for inhibiting expression of mutant EGFR geneSAH DINAH·Filed 2012·Granted Dec 15, 2015·24 cites·21 claims
1790US9101643B2Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR)SAH DINAH WEN-YEE·Filed 2010·Granted Aug 11, 2015·14 cites·4 claims
1889US11752181B2Compositions and methods of treating Huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2018·Granted Sep 12, 2023·4 cites·21 claims
1989US7691824B2Compositions and methods for inhibiting expression of a gene from the JC virusALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Apr 6, 2010·8 cites·15 claims
2088US2025146000A1Compositions and methods of treating amyotrophic lateral sclerosis (als)VOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
2187US11512327B2Compositions and methods for delivery of AAVVOYAGER THERAPEUTICS INC·Filed 2018·Granted Nov 29, 2022·3 cites·24 claims
2286US11931375B2Treatment of amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2022·Granted Mar 19, 2024·1 cites·24 claims
2386US2024401060A1Compositions and methods for inhibiting expression of mutant egfr geneALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
2485US8119114B2Polymer conjugates of mutated neublastinSAH DINAH WEN-YEE·Filed 2008·Granted Feb 21, 2012·3 cites·60 claims
2584US12123002B2Compositions and methods of treating amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2022·Granted Oct 22, 2024·0 cites·20 claims
2683US12227744B2Compositions and methods for inhibiting expression of transthyretinALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Feb 18, 2025·0 cites·11 claims
2781US8080532B2Compositions and methods for inhibiting expression of Huntingtin geneSAH DINAH WEN-YEE·Filed 2009·Granted Dec 20, 2011·2 cites·24 claims
2881US2025084435A1Treatment of amyotrophic lateral sclerosis (als)VOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
2980US9006197B2Compositions and methods for inhibiting expression of Eg5 and VEGF genesBUMCROT DAVID·Filed 2012·Granted Apr 14, 2015·4 cites·27 claims
3079US2023053332A1Compositions and methods for inhibiting expression of mutant egfr geneALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
3178US2024285667A1Central nervous system targeting polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
3277US12116589B2Treatment of amyotrophic lateral sclerosis (ALS)VOYAGER THERAPEUTICS INC·Filed 2022·Granted Oct 15, 2024·0 cites·20 claims
3377US12084659B2Modulatory polynucleotidesVOYAGER THERAPEUTICS INC·Filed 2021·Granted Sep 10, 2024·0 cites·24 claims
3477US8058257B2Compositions and methods for inhibiting expression of a gene from the JC virusTAN PAMELA·Filed 2010·Granted Nov 15, 2011·2 cites·16 claims
3577US2025376682A1Compositions and methods for inhibiting expression of transthyretinALNYLAM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
3677US2024415868A1Compositions and methods for treating huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
3777US2024325427A1Treatment of amyotrophic lateral sclerosis (als)VOYAGER THERAPEUTICS INC·Filed 2024·Application pending·0 cites
3876US12305189B2Compositions and methods for delivery of AAVVOYAGER THERAPEUTICS INC·Filed 2022·Granted May 20, 2025·0 cites·6 claims
3975US8642732B2Polymer-conjugated glycosylated neublastinSAH DINAH WEN-YEE·Filed 2012·Granted Feb 4, 2014·2 cites·22 claims
4075US7902168B2Compositions and methods for inhibiting expression of Nav1.8 geneALNYLAM PHARMACEUTICALS INC·Filed 2009·Granted Mar 8, 2011·1 cites·11 claims
4175US2024226203A9Compositions and methods of treating huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
4274US12146150B2Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous deliveryVOYAGER THERAPEUTICS INC·Filed 2022·Granted Nov 19, 2024·0 cites·20 claims
4374US9339513B2Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genesGOLLOB JARED·Filed 2011·Granted May 17, 2016·4 cites·28 claims
4474US2020283766A1Compositions and Methods for Inhibiting Expression of TransthyretinALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
4573US2020199592A1siRNA Therapy for Transthyretin (TTR) Related Ocular AmyloidosisALNYLAM PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
4672US2023399642A1Compositions and methods of treating huntington's diseaseVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
4772US2023295663A1Compositions and methods of treating amyotrophic lateral sclerosis (als)VOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
4871US2022307083A1Assays and methods for determining activity of a therapeutic agent in a subjectALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
4970US2020377893A1Compositions and methods for inhibiting expression of mutant egfr geneALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
5069US8318693B2Compositions and methods for inhibiting expression of mutant EGFR geneSAH DINAH·Filed 2009·Granted Nov 27, 2012·0 cites·20 claims

Showing the top 50 of 114 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Dinah Wen-Yee Sah files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →